442 related articles for article (PubMed ID: 30280327)
1. The effect of age, gender, and time between blood draw and start of centrifugation on the size outcomes of platelet-rich fibrin (PRF) membranes.
Miron RJ; Dham A; Dham U; Zhang Y; Pikos MA; Sculean A
Clin Oral Investig; 2019 May; 23(5):2179-2185. PubMed ID: 30280327
[TBL] [Abstract][Full Text] [Related]
2. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.
Dohan Ehrenfest DM; Pinto NR; Pereda A; Jiménez P; Corso MD; Kang BS; Nally M; Lanata N; Wang HL; Quirynen M
Platelets; 2018 Mar; 29(2):171-184. PubMed ID: 28437133
[TBL] [Abstract][Full Text] [Related]
3. Comparison of platelet-rich fibrin (PRF) produced using 3 commercially available centrifuges at both high (~ 700 g) and low (~ 200 g) relative centrifugation forces.
Miron RJ; Xu H; Chai J; Wang J; Zheng S; Feng M; Zhang X; Wei Y; Chen Y; Mourão CFAB; Sculean A; Zhang Y
Clin Oral Investig; 2020 Mar; 24(3):1171-1182. PubMed ID: 31321574
[TBL] [Abstract][Full Text] [Related]
4. Impact of different platelet-rich fibrin (PRF) procurement methods on the platelet count, antimicrobial efficacy, and fibrin network pattern in different age groups: an in vitro study.
Mamajiwala AS; Sethi KS; Raut CP; Karde PA; Mangle NM
Clin Oral Investig; 2020 May; 24(5):1663-1675. PubMed ID: 31346783
[TBL] [Abstract][Full Text] [Related]
5. Extending the working properties of liquid platelet-rich fibrin using chemically modified PET tubes and the Bio-Cool device.
Miron RJ; Horrocks NA; Zhang Y; Horrocks G; Pikos MA; Sculean A
Clin Oral Investig; 2022 Mar; 26(3):2873-2878. PubMed ID: 34816309
[TBL] [Abstract][Full Text] [Related]
6. Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols.
Fujioka-Kobayashi M; Katagiri H; Kono M; Schaller B; Zhang Y; Sculean A; Miron RJ
Clin Oral Investig; 2020 Dec; 24(12):4373-4383. PubMed ID: 32382929
[TBL] [Abstract][Full Text] [Related]
7. The effect of resting and compression time post-centrifugation on the characteristics of platelet rich fibrin (PRF) membranes.
Wei Y; Cheng Y; Wang Y; Zhang X; Miron RJ; Zhang Y
Clin Oral Investig; 2022 Aug; 26(8):5281-5288. PubMed ID: 35451655
[TBL] [Abstract][Full Text] [Related]
8. Effect of centrifugation time on growth factor and MMP release of an experimental platelet-rich fibrin-type product.
Eren G; Gürkan A; Atmaca H; Dönmez A; Atilla G
Platelets; 2016 Jul; 27(5):427-32. PubMed ID: 26830681
[TBL] [Abstract][Full Text] [Related]
9. Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept).
El Bagdadi K; Kubesch A; Yu X; Al-Maawi S; Orlowska A; Dias A; Booms P; Dohle E; Sader R; Kirkpatrick CJ; Choukroun J; Ghanaati S
Eur J Trauma Emerg Surg; 2019 Jun; 45(3):467-479. PubMed ID: 28324162
[TBL] [Abstract][Full Text] [Related]
10. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?
Miron RJ; Fujioka-Kobayashi M; Hernandez M; Kandalam U; Zhang Y; Ghanaati S; Choukroun J
Clin Oral Investig; 2017 Nov; 21(8):2619-2627. PubMed ID: 28154995
[TBL] [Abstract][Full Text] [Related]
11. Delayed centrifugation weakens the in vitro biological properties of platelet-rich fibrin membranes.
Robin W; Shuichiro K; Leeni K; Rana T; Reginaldo G; Lari H; Larjava H
Clin Oral Investig; 2024 Mar; 28(4):225. PubMed ID: 38514526
[TBL] [Abstract][Full Text] [Related]
12. Effects of platelet-rich fibrin produced by three centrifugation protocols on bone neoformation in defects created in rat calvaria.
Ferreira Sávio DS; Silva LMPD; Reis GGD; Denardi RJ; Costa NMMD; Chaves Furlaneto FA; Souza SLS; Mourão CFAB; Miron RJ; Okamoto R; Messora MR
Platelets; 2023 Dec; 34(1):2228417. PubMed ID: 37409489
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane.
Dohan Ehrenfest DM; Del Corso M; Diss A; Mouhyi J; Charrier JB
J Periodontol; 2010 Apr; 81(4):546-55. PubMed ID: 20373539
[TBL] [Abstract][Full Text] [Related]
14. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept.
Choukroun J; Ghanaati S
Eur J Trauma Emerg Surg; 2018 Feb; 44(1):87-95. PubMed ID: 28283682
[TBL] [Abstract][Full Text] [Related]
15. A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation.
Miron RJ; Chai J; Zheng S; Feng M; Sculean A; Zhang Y
J Biomed Mater Res A; 2019 Oct; 107(10):2257-2271. PubMed ID: 31148358
[TBL] [Abstract][Full Text] [Related]
16. Optimization of platelet-rich fibrin.
Miron RJ; Fujioka-Kobayashi M; Sculean A; Zhang Y
Periodontol 2000; 2024 Feb; 94(1):79-91. PubMed ID: 37681522
[TBL] [Abstract][Full Text] [Related]
17. Standardization of relative centrifugal forces in studies related to platelet-rich fibrin.
Miron RJ; Pinto NR; Quirynen M; Ghanaati S
J Periodontol; 2019 Aug; 90(8):817-820. PubMed ID: 30730050
[TBL] [Abstract][Full Text] [Related]
18. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma.
Wang X; Zhang Y; Choukroun J; Ghanaati S; Miron RJ
Platelets; 2018 Jan; 29(1):48-55. PubMed ID: 28351189
[TBL] [Abstract][Full Text] [Related]
19. A Standardized
Al-Maawi S; Dohle E; Kretschmer W; Rutkowski J; Sader R; Ghanaati S
Tissue Eng Part A; 2022 Apr; 28(7-8):353-365. PubMed ID: 34555949
[TBL] [Abstract][Full Text] [Related]
20. Long-term cytokine and growth factor release from equine platelet-rich fibrin clots obtained with two different centrifugation protocols.
Jiménez-Aristizabal RF; López C; Álvarez ME; Giraldo C; Prades M; Carmona JU
Cytokine; 2017 Sep; 97():149-155. PubMed ID: 28648869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
